Advanced Therapies
These therapies go beyond the fundamentals. They are explored by longevity researchers but require medical supervision.
Medical warning
These interventions require medical supervision. Consult a healthcare professional before starting any new protocol.
Prescription medications
Some medications show promising longevity effects in animal studies and are being explored in human research.
Rapamycin
mTOR inhibitor. Animal studies show significant life extension. Human use still experimental.
Simplified mechanism
Rapamycin inhibits mTOR (mammalian target of rapamycin), a protein that regulates cell growth. By inhibiting it, it activates autophagy — the cellular cleanup process that removes damaged components.
Key studies
Potential side effects
- Mouth sores
- Delayed wound healing
- Immunosuppression at high doses
- Dyslipidemia
Acarbose
Alpha-glucosidase inhibitor. Reduces post-meal blood sugar spikes. Potential anti-aging effect via mTOR pathway.
Simplified mechanism
Acarbose slows digestion of complex carbohydrates by inhibiting alpha-glucosidase enzymes. This reduces post-meal glucose spikes, thereby reducing stress on mTOR and associated aging pathways.
Key studies
- ITP: +22% lifespan in male mice, +5% in females (lien)
- Reduced lung tumors and liver degeneration in mice
Potential side effects
- Flatulence
- Abdominal distension
- Diarrhea (especially initially)
Rapamycin + Acarbose Combination
The combination of these two molecules shows potential synergy in animal studies, as the mechanisms are complementary (autophagy + glycemic control). This approach is explored by some longevity-focused physicians but remains experimental in humans.
Senolytics: clearing "zombie" cells
With age, certain cells fail to die and instead secrete a pro-inflammatory cocktail (SASP) that degrades neighboring tissues. Periodically clearing them significantly extends lifespan in mice; the first human clinical trials are now underway.
p16 / SASP mechanism
Senescent cells are marked by the inhibitors p16INK4a and p21. They continuously secrete a Senescence-Associated Secretory Phenotype (SASP) — IL-6, IL-8, MMP-9 — that drives chronic low-grade inflammation. Their targeted clearance in mice (INK-ATTAC model, van Deursen 2011) extended lifespan by 24 to 27%.
Candidates under clinical investigation
- Dasatinib + Quercetin (D+Q). "Hit-and-run" approach: 3 days of dosing, effects persist 11 days after withdrawal. First human trial (DKD 2019) targeted diabetic kidney disease.
- Fisetin. Natural flavonoid with documented senolytic activity in animals. Several clinical trials underway, dosing not yet standardized.
Strict caution required
Over 30 clinical trials are underway, but no protocol has yet received approval for this indication. Any use must be under qualified medical supervision — never as self-medication. Senolytics may also disrupt the beneficial functions of senescent cells (wound healing, immunity).
Read the full analysis : Cellular senescence: when your cells refuse to die
GLP-1 agonists: semaglutide and tirzepatide
Originally developed for type 2 diabetes and weight loss, GLP-1 agonists now show cardiovascular, metabolic, and inflammatory benefits that position them as a new therapeutic class with longevity relevance.
Major clinical data
- Semaglutide (SELECT trial, 2023). In 17,604 overweight patients with prior cardiovascular disease and without diabetes: −15 to −17% body weight, and notably −20% major adverse cardiovascular events (MACE) over 3 years.
- Tirzepatide (dual GLP-1 / GIP agonist). Up to −22.5% body weight at 72 weeks (SURMOUNT-1 study). Cardiovascular effects under evaluation in dedicated trials.
Extended mechanism
Beyond satiety and glycemic control (pancreatic insulin secretion, slowed gastric emptying), GLP-1 agonists reduce systemic inflammation, improve endothelial function, and partially cross the blood-brain barrier with neuroprotective effects under active investigation.
Strict medical prescription only
Reserved for medical prescription with validated indication. Never to be confused with so-called "research grade" peptides sold online — their purity and dosing are uncontrolled and the safety risk is high.
Read the full analysis : Longevity pharmacology: molecules under scientific surveillance
Regular blood donation
Blood donation presents several potential longevity benefits, beyond the altruistic act. (lien)
- Reduces iron overload (elevated ferritin = risk factor)
- Stimulates production of new blood cells
- Dilutional effect on circulating pro-aging factors
- Frequency: according to medical recommendations and eligibility
Red light therapy
Red/near-infrared light therapy stimulates mitochondria and promotes tissue regeneration.
Mechanism: Red light is absorbed by cytochrome c oxidase in mitochondria, increasing ATP production and releasing NO (nitric oxide). This stimulates cellular respiration and regeneration. (lien)
630-670nm (red) and 810-850nm (near-infrared)
10 min/day, full body or targeted areas
Collagen production, wound healing, mitochondrial health, muscle recovery
Finnish dry sauna
Finnish dry sauna has the strongest clinical evidence of all sauna types. Its mechanism is unique and cannot be replaced by infrared or steam rooms.
Recommended type: Finnish dry sauna (NOT infrared or steam)
Dry sauna has the strongest clinical evidence and a unique thermal stress mechanism.
Recommended parameters
80-100°C (175-212°F)
3-7x/week (optimal 4-7x)
15-20 min per session
Proven results
- -63% cardiovascular mortality (4-7x/week vs 1x) (lien)
- -40% all-cause mortality
- Massive detoxification: 2,4-D -65%, several toxins reduced to undetectable
- Central blood pressure improvement -12.6%
Male fertility protection
Sauna heat affects sperm production. Simple protection can preserve — even improve — fertility.
Without protection (15 sessions)
- -54% motile count
- -57% motility
- -55% normal morphology
With protection (27 sessions)
- +57% motile count
- +26% concentration
- +16% motility
- +15% morphology
Ice protocol
Non-toxic reusable ice pack. Cotton boxer + shorts, pack between the two. Maintain throughout the session.
Rehydration: 1L mineralized water after each session.
Contraindications
- Serious heart problems
- Uncontrolled hypertension
- Pregnancy (consult doctor)
- Fever/infection
- History of seizures
- Respiratory conditions (asthma, COPD)
- Irritated/inflamed skin
- Recent alcohol/drugs
- Medications: beta-blockers, stimulants, anticholinergics, diuretics
Hyperbaric Oxygen Therapy (HBOT)
HBOT is among the highest-value therapies for longevity. It requires access to specialized facilities. (lien)
HBOT Protocol
100% O2 at 2 atmospheres
60 sessions, 5x/week
90 min (20 min O2 + 5 min air break, repeat)
Hard shell, pressurized ambient air + 100% O2 mask
Avoid 100% ambient O2 chambers: Eye irritation and cataract risk. Higher ignition risk. Difficult to take breaks.
Expensive therapy, limited access. Individual results vary.
Cold exposure: between hormesis and caveats
Controlled cold exposure (cold plunge at 5-15°C, whole-body cryotherapy at -110°C, cold showers) activates brown fat, raises noradrenaline and dopamine, and induces mitohormesis. Human longevity evidence is less robust than for sauna, but short-term benefits on mood, recovery, and insulin sensitivity are well documented.
Reference protocol
- →Cold plunge: 5 to 15°C, 2 to 5 minutes, 2 to 3 times per week
- →Whole-body cryotherapy: -110 to -140°C, 2 to 3 minutes maximum, supervised
- →Final cold shower: 30 seconds to 2 minutes, accessible daily
- →Acute effects measured: noradrenaline +200 to +500%, dopamine +250%, improved insulin sensitivity, mitohormetic signal
When to avoid or adapt
Not within an hour of resistance training: may blunt hypertrophy. Contraindications: unstable cardiovascular disease, severe Raynaud's syndrome, pregnancy. Beyond 10 minutes without acclimatization, prolonged cold tips into deleterious sympathetic stress rather than hormesis.
Meditation, breathing, heart-rate coherence
Structured mental practices are not a cultural luxury: they modulate the HPA axis, raise parasympathetic tone, and lower low-grade inflammatory markers. Cumulative clinical evidence now positions them as a longevity intervention in their own right.
Validated practices
- Mindfulness-Based Stress Reduction (MBSR). Structured 8-week programs: lower hsCRP, lower IL-6, higher telomerase activity. Daily target: 10 to 20 minutes. Reference apps: Petit BamBou, Headspace, Calm.
- Heart-rate coherence breathing. 5 / 5 breathing (5-second inhale, 5-second exhale) for 5 minutes, three times a day. Restores heart rate variability (HRV) and anchors parasympathetic tone. Tools: Respi Relax+, Oak.
- NSDR (Non-Sleep Deep Rest) / Yoga Nidra. 10 to 30 minutes during the day. Restores dopamine beyond the gain from pure sleep (popularized by Andrew Huberman). Guided audio is sufficient — no prior expertise required.
- Wim Hof Method. Cyclic hyperventilation followed by breath holds. Activates the sympathetic nervous system in a controlled manner. Solid short-term data (reduced inflammatory markers under endotoxic challenge). Practice seated, never in water.
Therapeutic Plasma Exchange (TPE)
Heterochronic parabiosis in mice (Conboy 2005) showed that young blood rejuvenates certain tissues in older subjects. The scientific debate has since shifted: it is the pro-aging factors in plasma that dominate, more than the young factors. TPE — plasma exchange with albumin replacement — reproduces this effect by diluting systemic aging factors.
Key evidence
- →Mehdipour (2020): saline-albumin TPE reproduces in mice the benefits observed in heterochronic parabiosis
- →FDA-approved for over 50 clinical indications (autoimmunity, neurology)
- →Outpatient procedure of 1 to 2 hours, no donor blood involved
Anti-Ambrosia: no donor plasma
Commercial clinics injecting young plasma (Ambrosia-style operations, shut down by the FDA in 2019) have no scientific basis. Therapeutic TPE uses albumin as the replacement, never human donor plasma. To be considered only on medical indication and in a certified center.
Read the full analysis : Heterochronic parabiosis: can young blood reverse aging?
Other medications explored
These medications have approved indications but are being studied for their potential longevity effects.
Improves endothelial function, reduces inflammation, potential cardiovascular protection. (lien)
Angiotensin receptor blocker (ARB), reduces blood pressure, protects kidney function, possible brain inflammation reduction. (lien)
SGLT-2 inhibitor (blocks kidney glucose reabsorption), caloric restriction mimetic, proven cardiac protection. (lien)
Anti-PCSK9 antibody (inhibits PCSK9 protein that regulates LDL elimination), LDL cholesterol optimization for those who can't tolerate statins. (lien)
Insulin sensitizer, potential anti-aging effects. TAME study ongoing. (lien)